PGE2 receptors rescue motor neurons in a model of amyotrophic lateral sclerosis
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Recent studies suggest that the inducible isoform of cyclooxygenase, COX‐2, promotes motor neuron loss in rodent models of ALS. We investigated the effects of PGE 2, a principal downstream prostaglandin product of COX‐2 activity, on motor neuron survival in an organotypic culture model of ALS. We find that PGE 2 paradoxically protects motor neurons at physiological concentrations in this model. PGE 2 exerts its downstream effects by signaling through a class of four distinct G‐protein–coupled E‐prostanoid receptors (EP1–EP4) that have divergent effects on cAMP. EP2 and EP3 are dominantly expressed in ventral spinal cord in neurons and astrocytes, and activation of these receptor subtypes individually or in combination also rescued motor neurons. The EP2 receptor is positively coupled to cAMP, and its neuroprotection was mimicked by application of forskolin and blocked by inhibition of PKA, suggesting that its protective effect is mediated by downstream effects of cAMP. Conversely, the EP3 receptor is negatively coupled to cAMP, and its neuroprotective effect was blocked by pertussis toxin, suggesting that its protective effect is dependent on Gi‐coupled heterotrimeric signaling. Taken together, these data demonstrate an unexpected neuroprotective effect mediated by PGE 2, in which activation of its EP2 and EP3 receptors protected motor neurons from chronic glutamate toxicity. Ann Neurol 2004;56:240–248
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis
Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Prostanoid Receptors: Subtypes and Signaling
Breyer, R. M., Bagdassarian, C. K., Myers, S. A., & Breyer, M. D. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.661 · Cited by 1,011 · cited 3×
“The increase in cAMP levels after butaprost stimulation in spinal cord slices is consistent with observations in nonneuronal cells that demonstrate a positive coupling of the EP2 receptor with cAMP production.(17) Because studies have correlated increases in cAMP with neuroprotection in several paradigms of neuronal i…”
BackgroundMethodResultNeuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483 · cited 1×
“Recent studies raise the possibility that integrated downstream effects of COX-2 activity could have an impact on the regulation of cell cycle proteins, findings that are relevant to emerging evidence of aberrant cell cycle activity in neurodegeneration.(54) PGE2 is generally considered to be a proinflammatory molecul…”
BackgroundInflammatory processes in amyotrophic lateral sclerosis
McGeer, P. L., & McGeer, E. G. (2002) · Muscle & Nerve · doi:10.1002/mus.10191 · Cited by 470
Cited by
Inflammatory processes in Alzheimer's disease
Heneka, M. T., & O'Banion, M. K. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.11.017 · Cited by 782
Neuroinflammatory processes in Alzheimer’s disease
Heneka, M. T., O’Banion, M. K., Terwel, D., & Kummer, M. P. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0438-z · Cited by 433
“…of the role of neuronal EP2 acti- vation on neuronal cell death have yielded conflicting results and suggest a neuroprotective role of neuronal EP2 stimulation under several pathophysiological circum- stances (Bilak et al. 2004; Lee et al. 2004; McCullough et al. 2004; Takadera et al. 2004).”
ResultProstaglandin E2 EP1 receptors: downstream effectors of COX-2 neurotoxicity
Kawano, T., Anrather, J., Zhou, P., Park, L., Wang, G., Frys, K. A., Kunz, A., Cho, S., Orio, M., & Iadecola, C. (2006) · Nature Medicine · doi:10.1038/nm1362 · Cited by 374
Neuroglia in neurodegeneration
Heneka, M. T., Rodríguez, J. J., & Verkhratsky, A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.11.004 · Cited by 301
Trial of celecoxib in amyotrophic lateral sclerosis
Cudkowicz, M. E., Shefner, J. M., Schoenfeld, D. A., Zhang, H., Andreasson, K. I., Rothstein, J. D., Drachman, D. B., & Northeast ALS Consortium (2006) · Annals of Neurology · doi:10.1002/ana.20903 · Cited by 301
Self-citationFrisardi, V., Panza, F., Seripa, D., Farooqui, T., & Farooqui, A. A. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.001 · Cited by 229
Emerging roles of PGE2 receptors in models of neurological disease
Andreasson, K. (2010) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2009.04.003 · Cited by 219
Self-citationProstaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection
Jiang, J., & Dingledine, R. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.05.003 · Cited by 166
Molecular and cellular immune mediators of neuroprotection
Turrin, N. P., & Rivest, S. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:3:221 · Cited by 85
Cantaut-Belarif, Y., Antri, M., Pizzarelli, R., Colasse, S., Vaccari, I., Soares, S., Renner, M., Dallel, R., Triller, A., & Bessis, A. (2017) · Journal of Cell Biology · doi:10.1083/jcb.201607048 · Cited by 56
“2985 been detected mostly in neurons (Bilak et al., 2004; Zhao et al., 2007; Liang et al., 2008).”
BackgroundResultPalumbo, S., Toscano, C. D., Parente, L., Weigert, R., & Bosetti, F. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07363.x · Cited by 46
“In contrast, PGE2 signaling via EP2 and EP4 was neuroprotective during excitotoxicity in neurons (Bilak et al. 2004).”
Are professional soccer players at higher risk for ALS?
Beghi, E. (2013) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2013.809764 · Cited by 39
Metadata
- Authors
- Bilak, M., Wu, L., Wang, Q., Haughey, N., Conant, K., St. Hillaire, C., & Andreasson, K.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2004-07-29
- Volume
- 56
- Issue
- 2
- Pages
- 240-248
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2050581353
- Cited by
- 126
- References
- 5
- FWCI
- 6.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.